Breaking News
November 21, 2018 - Study explores individual and organizational risk factors for one-year mortality in ICU survivors
November 21, 2018 - Pulmonologists want more information on inhalation devices for COPD
November 21, 2018 - Cessation fatigue predicts relapse rate after attempts to quit smoking
November 21, 2018 - Special care should be taken with drugs that inhibit epigenetic factors, study suggests
November 21, 2018 - More than one in ten heavy cannabis users experience withdrawal after quitting cannabis
November 21, 2018 - Reflections on the California fires
November 21, 2018 - Donna Lynne Appointed to Key Leadership Role at CUIMC
November 21, 2018 - Smoke-free laws associated with reduced systolic blood pressure
November 21, 2018 - Achieving new guideline blood pressure goals may prevent 3 million cardiovascular events
November 21, 2018 - LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data
November 21, 2018 - Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study
November 21, 2018 - Study warns that potential epigenetic therapy may boost lung cancer stem cells
November 21, 2018 - Noise pollution in hospital impact quality and safety of healthcare
November 21, 2018 - Higher Risk for Amputation, DKA With SGLT2 Inhibitors for T2DM
November 21, 2018 - Researchers stop ‘sneaky’ cancer cells in their tracks
November 21, 2018 - People who are afraid to draw their blood over-estimate the risk of fainting
November 21, 2018 - Personalized physical exercise reverses functional, cognitive deterioration in the elderly
November 21, 2018 - COPD linked to obesity in older women who have never smoked
November 21, 2018 - AHA: Cold-Weather Drinks Are Here, But Watch Out for the Calories
November 21, 2018 - Crowds line up at 1st East Coast pot shops
November 21, 2018 - Merck declares 2018 Life Science Award winners
November 21, 2018 - Many people underestimate the impact of sprains, say foot scientists
November 21, 2018 - Lower levels of protein make squamous carcinoma cells more invasive
November 21, 2018 - Study highlights a new predictor of type 2 diabetes
November 21, 2018 - NTU and TTSH join forces to improve doctor-patient communication
November 21, 2018 - New low-cost injectable hydrogel could help wounds heal faster
November 21, 2018 - Merck Announces Winners of 2018 Life Science Awards
November 21, 2018 - Check your medical records for dangerous errors
November 21, 2018 - Amount of weight regain after bariatric surgery helps predict health risks
November 21, 2018 - Heart failure patients with stronger hearts have more depressive symptoms, lower quality of life
November 21, 2018 - Women can be as resilient as men in undertaking arduous physical activity
November 21, 2018 - Receptor structure could be key to developing new osteoporosis drugs
November 21, 2018 - Researchers identify human white matter pathway associated with individual variability in human stereoacuity
November 21, 2018 - Vitamin D critical to early development of vertebrates, study suggests
November 21, 2018 - Myriad biological, societal factors that impact CKD severity for children of African descent
November 21, 2018 - Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer
November 21, 2018 - Experts offer more clarity on managing common ankle fractures
November 21, 2018 - About 300 million bits of DNA are missing from basic reference genome, report scientists
November 21, 2018 - Study explores how the moving brain processes visual information
November 21, 2018 - Biomedical engineers stop cancer cells from moving and spreading
November 21, 2018 - Gut protein mutations protect against spikes in blood glucose levels
November 21, 2018 - First probabilistic atlas of thalamus nuclei to better understand the brain
November 21, 2018 - Peanut allergies could soon have a drug treatment
November 21, 2018 - Vanderbilt researchers isolate antibody that can neutralize West Nile virus
November 21, 2018 - KHN’s ‘What the Health?’ Health nerd books for the holidays
November 21, 2018 - MDMA could help gain trust but does not make one naive find researchers
November 21, 2018 - Study uncovers new mechanism controlling the master cancer regulator
November 21, 2018 - Online communication technologies could stave off depression among seniors, shows study
November 21, 2018 - FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
November 21, 2018 - Artificial intelligence predicts treatment effectiveness
November 21, 2018 - A bicyclist’s road to recovery after traumatic brain injury
November 21, 2018 - New research project to combat obesity, type 2 diabetes receives NIH funding
November 21, 2018 - Humans play key role in distribution and transmission of Bartonella bacteria
November 21, 2018 - First modeling system developed for testing age-specific human immune responses to vaccines
November 21, 2018 - FDA Alert: Gilenya (fingolimod): Drug Safety Communication
November 21, 2018 - Uric Acid Test: MedlinePlus Lab Test Information
November 21, 2018 - Researchers use genetics to predict response to antipsychotic medications
November 21, 2018 - Proposal to include the price of drugs in television ads is flawed, Stanford scholar writes
November 21, 2018 - Disrupting reproduction strategy of disease-causing parasites could help fight malaria
November 20, 2018 - ACAAI: Almost 2 Percent of Children Have Milk Allergy
November 20, 2018 - Congenital anomalies of kidney and urinary tract – Genetics Home Reference
November 20, 2018 - Can video games improve the health of older adults with schizophrenia?
November 20, 2018 - Can flicking a molecular switch restore the aging immune system’s competence?
November 20, 2018 - Restek launches new Oregon cannabis pesticide standards
November 20, 2018 - Health sector coalition urges Government to safeguard patients in future UK-EU relationship
November 20, 2018 - Study evaluates second-hand marijuana smoke exposure among children
November 20, 2018 - Scientists identify three genes responsible for recurrent molar pregnancies
November 20, 2018 - Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene
November 20, 2018 - Dining Out With Allergies Is Tough, But These Steps Can Help
November 20, 2018 - Breastfeeding protects infants from antibiotic-resistant bacteria
November 20, 2018 - AI matched, outperformed radiologists in screening X-rays for certain diseases | News Center
November 20, 2018 - Adolescents increasingly choose marijuana over cigarettes, alcohol
November 20, 2018 - World’s first medical imaging scanner produces diagnostic scan of the whole human body
November 20, 2018 - Cytocybernetics receives NIMH award to move into neuronal drug development
November 20, 2018 - Researchers discover new information on pathological mechanisms of Alzheimer’s disease
November 20, 2018 - ‘Unknown’ enzyme may be key to new treatment for inflammatory diseases
November 20, 2018 - Recreational drug may help people regain trust in others
November 20, 2018 - Researchers identify gene vital for post-stroke recovery
November 20, 2018 - Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury
November 20, 2018 - Potential new therapeutic approach developed for synovial sarcoma
Researchers propose new strategy to combat micro-pollutants in water

Researchers propose new strategy to combat micro-pollutants in water

image_pdfDownload PDFimage_print

Pharmaceutical residues from domestic dwellings, hospitals and agriculture are contaminating our water. The introduction of a strategy to handle micro-pollutants aims to solve this problem in Germany in the future. However, the issue of how this is to be financed has to be addressed. One option would be the introduction of a payment scheme for the use of pharmaceutical products that pose a risk to water sources and supplies. For this reason, a mechanism for charging for pharmaceutical products, which takes into account both the legal and economic issues, has been discussed in greater detail in a scientific report produced by Helmholtz Centre for Environmental Research researchers for the Federal Environmental Agency (UBA) in Germany.

The effects of the medicines we take often reach far beyond our bodies. This is because water treatment plants are currently unable to remove many of the pharmaceutical residues, such as hormones or the analgesic Diclofenac, from waste water. These residues are more or less impervious to the treatment process, and therefore pass into the “treated” waste water and then into the environment. Residues of prescribed veterinary medicines are also a problem in the agricultural industry. They pass into animal manure, which is spread on the fields, where the rain washes it into rivers and into the ground water. These micro-pollutants can damage aquatic organisms and represent a serious environmental problem. And that’s not all: they can even pass through the drinkable water barrier, and might well have negative effects on our health. So, what can we do to curb the incursion of micro-pollutants into our water?

Of course, it would be a good idea just to avoid using substances that pollute water in the first place. Nevertheless, this is not always possible – especially when it comes to medicine. However, there is a technical solution: “As part of a policy mix the “fourth treatment stage”, as we call it, is a proven method for removing the majority of micro-pollutants from waste water. It can simply be implemented after the three standard treatment stages in selected waste water treatment plants”, explained Prof. Erik Gawel from the Helmholtz Centre for Environmental Research. “This involves mature technology, which is available at an acceptable cost.” However, the question of how to finance the installation of this fourth treatment stage at selected waste water treatment plants in Germany needs to be resolved, unless everything is to be paid for by sewerage charges. The introduction of a charging scheme for pharmaceutical products is discussed here, as a means of making manufacturers take some responsibility before the residues enter the water system.

At the request of the German Federal Environmental Agency (UBA), Erik Gawel and his colleagues at the Helmholtz Centre for Environmental Research have written a report in which they described a strategy for charging for pharmaceutical products, taking into account all the legal and commercial issues involved. “From a legal point of view, introducing a charging scheme for pharmaceutical products wouldn’t cause any particular legal problems and it would actually make good economic sense,” said the environmental economist. “Tax revenues could also provide adequate finance for retro-fitting the fourth treatment stage in selected waste water treatment plants throughout Germany.” Although it would be possible to finance this through taxation, or increasing the sewerage charge for the treatment plants involved, the scientist thinks this option would be unfair. “The production and use of substances that damage our water generate costs that polluters should bear. But why should all taxpayers have to foot the bill?”, asked Gawel. “From our point of view, making the polluters the ones who pay would be fairer. And only increasing sewerage charges for the upgraded treatment plants would simply be arbitrary, because pharmaceutical residues affect our water everywhere.”

The researchers have proposed a three-tier tariff for handling water pollutants: if it is unclear whether a pharmaceutical product actually causes damage to water, either the manufacturer or its delivery point (e.g. pharmacy) must pay a charge for the product’s potential effect on water, as a precaution. An increased fee would be charged if it is clear that the product is a water pollutant. However, if it can be proven that the pharmaceutical product does not have any damaging effects on water, no fee would be charged for its active ingredients. “Manufacturers would have to prove that their products were not harmful to water”, said Gawel. “However, strict legal requirements would apply to the test processes used by the manufacturers.” The researchers also considered the possibility of having the contributory payment for human medicines reimbursed by health insurance companies. “This might only involve a very small, trivial amount of money, maybe as little as 50 Euro cents”, said Gawel. “The primary intention is to create an awareness that the use of pharmaceutical products containing substances that are hazardous to water generates additional costs for society as a whole. If the contributory payment option was implemented, it would not be applicable in the case of this trivial amount.”

In their report, the Helmholtz Centre for Environmental Research researchers strongly advocate the introduction of a charging scheme for pharmaceutical products as one of a range of mechanisms for financing the fourth treatment stage, and providing an effective, reasonably priced means of solving the problem of micro-pollutants. A comparable pesticide tax could make the case for micro-pollutants stemming from plant protection measures as well. “A charge on products ending up in micro-pollutants would make good commercial sense, would be legally possible, and also be very fair, in terms of its social impact”, said Gawel. “Until now, the pharmaceutical industry has taken little responsibility for the damage that residues of its products have caused to our water sources and water supplies. Charging for pharmaceutical products would have an important compensatory function as part of a comprehensive strategy for combating micro-pollutants in Germany.”

Source:

http://www.ufz.de/index.php?en=36336&webc_pm=21/2018

Tagged with:

About author

Related Articles